BioCT’s original co-founders remain its significant partners today. We honor their legacy with an enduring commitment to excellence and dedication in pursuit of our mission. Their foresight encouraged us in the beginning. Their tenacity helped us grow as a community. And their far-reaching innovation continues to help us imagine new futures. BioCT expresses deepest thanks to its legacy partners Boehringer Ingelheim, Pfizer, University of Connecticut and Yale University.